bibliographic entry 2492558 [be/2492558]
https://w3id.org/oc/corpus/be/2492558
- is a
-
- content
-
-
AstraZeneca, Multicenter trial to evaluate the effect of dapagliflozin on the incidence of cardiovascular events (DECLARE-TIMI58), Available from, https://clinicaltrials.gov/ct2/show/NCT01730534. NLM identifier: NCT01730534, Accessed January 8, 2016
- references
-